Metraipolis › archive › dc_cdcf86fb87c2

Safety monitoring of Imvamune vaccine during the 2022 mpox outbreak in Canada — Europe PMC PMID:40919221

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40919221
DOI: 10.14745/ccdr.v51i08a05
License (as archived): solo-consultazione
Archived: 2026-11-10T06:50:37.440Z
SHA-256 of the archived text: e92bd90a46a31e44775df79f3d7cbd491f0a145c9ca649621328108145ec0c30
Stable URL of this page: https://metraipolis.com/documento/dc_cdcf86fb87c2

How to cite

Safety monitoring of Imvamune vaccine during the 2022 mpox outbreak in Canada — Europe PMC PMID:40919221 — Europe PMC (en), https://europepmc.org/article/MED/40919221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cdcf86fb87c2 (Metraipolis archive dc_cdcf86fb87c2, sha256 e92bd90a46a31e44775df79f3d7cbd491f0a145c9ca649621328108145ec0c30)

BibTeX

@misc{dccdcf86fb87c2,
  title = {Safety monitoring of Imvamune vaccine during the 2022 mpox outbreak in Canada — Europe PMC PMID:40919221},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40919221},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cdcf86fb87c2; sha256 e92bd90a46a31e44775df79f3d7cbd491f0a145c9ca649621328108145ec0c30},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40919221. Agents can read the archived copy with the MCP tool read_document.